Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.795
+0.100 (5.90%)
Nov 6, 2025, 4:54 PM CET
Stenocare Revenue
Stenocare had revenue of 1.92M DKK in the quarter ending September 30, 2025, a decrease of -306.96%. This brings the company's revenue in the last twelve months to 5.67M, up 183.98% year-over-year. In the year 2024, Stenocare had annual revenue of 2.23M, down -40.60%.
Revenue (ttm)
5.67M
Revenue Growth
+183.98%
P/S Ratio
12.08
Revenue / Employee
709.22K
Employees
8
Market Cap
68.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.23M | -1.53M | -40.60% |
| Dec 31, 2023 | 3.76M | -731.58K | -16.30% |
| Dec 31, 2022 | 4.49M | 2.60M | 137.54% |
| Dec 31, 2021 | 1.89M | 1.69M | 852.38% |
| Dec 31, 2020 | 198.45K | -4.74M | -95.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 311.94B |
| Coloplast | 27.87B |
| H. Lundbeck | 23.52B |
| Genmab | 23.16B |
| Demant | 22.59B |
| GN Store Nord | 17.33B |
| Zealand Pharma | 9.11B |
| Bavarian Nordic | 6.46B |